Health Assessment Project

Embed Size (px)

Citation preview

  • 8/4/2019 Health Assessment Project

    1/32

    Health Assessment

    AsthmaUnderstanding Asthma

  • 8/4/2019 Health Assessment Project

    2/32

    Introduction-Identification

    Chronic Lung Disease that constricts airwaysand causes breathing difficulties

    Pravakar. 2011. Asthma symptoms. A1Health Source. Retrieved from http://www.a1healthnews.net/2011/07/asthma-symptoms/

    Pravakar. 2011. Asthmasymptoms. A1HealthSource. Retrievedfrom http://www.a1healthnews.net/2011/07/asthma-symptoms/

  • 8/4/2019 Health Assessment Project

    3/32

    Introduction-Definition

    What is Asthma?

    Asthma is a chronic lung disease that inflames and narrows

    the airways (NHLBI, 2011).

    Asthma may cause:

    Wheezing

    Shortness of Breath

    Trouble sleeping Coughing at night or early morning

    NHLBI. (2011). Asthma. U.S. Department of Health & Human Services. Retr ieved from http://w ww.nhlbi.nih.g ov/health/d ci/Diseases/Asthma/Ast hma_What Is.html

  • 8/4/2019 Health Assessment Project

    4/32

    Introduction-Incidence or Prevalence

    Source: Environmental Protection Agency: CDC National Center for Health Statistics

  • 8/4/2019 Health Assessment Project

    5/32

    Introduction-Incidence or Prevalence

    Source: Environmental Protection Agency: CDC National Center for Health Statistics

  • 8/4/2019 Health Assessment Project

    6/32

    Introduction-Incidence or Prevalence

    Source: Environmental Protection Agency: CDC National Center for Health Statistics

  • 8/4/2019 Health Assessment Project

    7/32

    Summary-Signs and Symptoms

    Symptoms Frequent coughing that worsens during high activity

    Recurrent wheezing

    Shortness of breath

    Chest tightness

    Difficulty breathing

    Chest tightness

    Symptoms that worsen at night or early in the morning

    Symptoms that are triggered by cold air, exercise and/ allergens

    Mayo Clinic. (2011). Asthma: steps in testing and diagnosis. Retrieved fromhttp://www.mayoclinic.com/print/asthma/AS00003/METHOD=print

  • 8/4/2019 Health Assessment Project

    8/32

    Summary of Relevant Evidence-EstablishedRisk Factors

    Established Risk Factors

    1. Genetics

    Bodys genetic make-up todevelop the antibody called

    immunoglobulin E (IgE).

    2. Allergies

    Grass

    Pollen

    Molds

    Dust & Dust Mites

    Animal dander

    Vitamin D Deficiency

    Foods

    Air pollution

    Tobacco smoke

  • 8/4/2019 Health Assessment Project

    9/32

    Summary of Relevant Evidence-

    Suspected Risk Factors

    Medical conditions

    Respiratory infection in

    childhood

    Low birth weight

    Gastrointestinal Reflux disease(GERD)

    Obesity (also increases Vitamin

    D deficiency) Congestive Heart Failure (CHF)

    Pulmonary Embolism

    Use of acetaminophen

    Exposure to Potential

    Allergens Second hand tobacco smoke

    Pets

    Mold

    Dust &Dust Mites

    Occupational Irritants such aschemicals used in Farming, beauty salons,

    manufacturing plants, fuel exhaust

    High levels of Air pollution

  • 8/4/2019 Health Assessment Project

    10/32

    Summary of Relevant Evidence-CurrentViewpoints about Disease Management

    The primary goal of asthma management is to control asthma,

    preventing asthma-related morbidity and mortality. Poorcontrol of asthma increases the risks of troublesome

    symptoms and hospitalization, and reduces patient quality oflife (Oh,Y. & Koh., 2011).

  • 8/4/2019 Health Assessment Project

    11/32

    Summary of Relevant Evidence-Current

    Viewpoints about Disease Management

    Environmental Control

    Avoid exposure to:

    Viral infections

    Environmental pollutants

    Tobacco smoke

    Irritant gases/chemicals

    Pollens

    Dust & Dust Mites

    Animal dander

  • 8/4/2019 Health Assessment Project

    12/32

    Summary of Relevant Evidence-Current

    Viewpoints about Disease Management

    Medications

    1. Relievers-used for acute asthma symptoms

    A. Fast Acting beta2-Agonist (also known as short acting beta2-

    Agonist)

    Salbutamol

    Terbutaline

    B. Long Acting beta2-Agonist

    Formoterol

  • 8/4/2019 Health Assessment Project

    13/32

    Summary of Relevant Evidence-Current

    Viewpoints about Disease Management

    Medications cont.

    Controllers- used to control chronic uncontrolled asthma

    1. Inhaled corticosteroid (ICS)

    2. Leukotriene Receptor antagonists (LTRAs)

    montelukast

    zafirlukast

    3. Long Acting beta2-Agonist

    fluticasone/salmeterol combination

    budesonid/formoterol combination

    4. Anti-immunoglobulin E

  • 8/4/2019 Health Assessment Project

    14/32

    Summary of Relevant Evidence-Current

    Viewpoints about Disease Management

    Management goals:

    Maintain control of symptoms

    Maintain normal activity levels

    Prevent asthma exacerbations

    Prevent asthma mortality

  • 8/4/2019 Health Assessment Project

    15/32

    Summary of Relevant Evidence-Current

    Literature on Nursing Interventions

    Nursing Interventions Educate patient and family about:

    Asthma and asthma triggers Recognizing symptoms

    What to do upon onset of symptoms

    Use of peak flow meter

    Medications

    Benefits

    Actions

    side affects

    proper use of regimen dose, time, and techniques

  • 8/4/2019 Health Assessment Project

    16/32

    Summary of Relevant Evidence-Current

    Literature on Nursing Interventions

    Nursing Interventions cont Develop a plan of Action to manage/control

    asthma Avoidance of viral infections

    Avoid environmental pollutants

    Educate on the removal of environmental asthmatriggers

    Behavior modifications to decrease stress

    What to do upon asthma attack

    Department of Public Health. ( 2010). Asthma action plan. State of Connecticut. Retrieved from http://ww w.ct.gov/dp h/cwp/view .asp?a=3137 &q=397020

  • 8/4/2019 Health Assessment Project

    17/32

  • 8/4/2019 Health Assessment Project

    18/32

    Health AssessmentStrategies-Expected

    abnormal findings

    Upper Respiratory tract: Increasednasal secretions, mucosal swelling

    Chest Sounds: Wheezes (continuoushigh pitched hissing sound) uponexpiration and sometimes inspiration.

    Barreled chest from hyper expandingthe thorax

    Use of accessory muscles

    Shoulders are hunched

    Source: NHLBI.

    http://www.nhlbi.nih.gov/health/dci/Diseases/Asthma/Asthma_What Is.html

  • 8/4/2019 Health Assessment Project

    19/32

    Health Assessment Strategies-Assessment Techniques

    Gathering information:

    1. Patient History:

    History of allergies

    Recent and past viral infections

    Hospitalizations

    Symptoms of dyspnea, wheezing, cough, chest tightness, anxiety

    2. Physical exam:

    Increased respiration rate

    Shortness of breath while at rest and can hardly speak

    Use of accessory muscles

    Increased anteroposterior thoracic diameter

    Pallor or cyanotic color

    Confusion

    Percussion may reveal a hyper resonance sound

    Auscultation: high pitched inspiratory and/or expiratory wheezes, prolongedexpiratory phase, rapid heart rate, limited to no breath sounds

  • 8/4/2019 Health Assessment Project

    20/32

    Screening Guidelines

    Screening done on individuals are performed on a patient

    history, history of asthmatic symptoms, Doctor diagnosis ofasthma, lung function test, allergy tests, patient education,

    and regular follow-up visits.

    Due to the incomplete understanding of asthma and the lackof tests to identify if a person symptomatic and non

    symptomatic will develop asthma, it is not possible at this

    time to screen whole populations for this disease (Boss, L., etal., 2003).

  • 8/4/2019 Health Assessment Project

    21/32

    Screening Guidelines-Implementation ofGuidelines into Nursing Practice

    Since nurses are in constant contact with asthma patients, they arein an ideal situation to promote, establish and maintain asthmacontrol, with the main focus of asthma management. EPR-3

    organizes asthma care around four components:1. Assessment and monitoring measures

    2. Education for a partnership in asthma care

    3. Control of environmental factors and comorbid conditions thataffect asthma

    4. Drug therapy

    NHLBI. (2007). Expert panel report 3: guidelines for the diagnosis and management of asthma. U.S. Department of Health and Human Services. R etrieved from

    http://www.nhlbi.nih.gov/guidelines/asthma/asthgdln.pdf

  • 8/4/2019 Health Assessment Project

    22/32

    Prevention Strategies-Non-drugMeasures to Reduce Incidence

    Reduce exposure to triggers that cause exacerbations

    Wash bedding weekly

    Keep living quarters dust free

    If allergic to animals, do not have them or at least wipe themdaily with a wet washcloth or disposable wipes

    Avoid exposure to tobacco smoke

    Quit smoking

    Limit exposure to environmental pollutions Limit exposure to pollens

    Eliminate molds

  • 8/4/2019 Health Assessment Project

    23/32

    Prevention Strategies-Measures to Dealwith High-Risk Patients

    Patients who have frequent and severe asthma symptoms andevidence of airflow limitation are at greatest risk. Therefore, any acuteexacerbation of asthma may be a potentially fatal attack (O'Hollaren,M., & Hartert,T.,2003). It is crucial to obtain and maintain control of

    the asthma and ensure the patient adheres to the individualized actionplan.

    Nurses can help manage high risk patients by: Educate the patient about asthma and treatment

    Devising an individualized Asthma Action Plan

    Reduce allergen exposure

    Regular follow up visits by clinician at least monthly

    Periodic consults with a pulmonologist or allergist

    Combination therapy with rescue and controller medications

    Adherence to Asthma Action Plan

    O'Hollaren ,M., & Hartert, T. (2003). Managing patients with high-risk asthma. Patient Care for the Nurse Practitioner, Retrieved from EBSCOhost.

  • 8/4/2019 Health Assessment Project

    24/32

    Conclusion-Importance of this Disease

    Cost to society Measured as a cost to society, the bill for asthma is staggering.

    In 1990 asthmas cost to society was $6.2 billion. Currently it is

    $11 billion, a figure that could rise to $18 billion by 2020. Bythen, asthma treatment will absorb $2 billion in Medicaid andMedicare dollars alone, double what we spend today.

    We are already facing a national crisis in our inability tounderstand and stem the rise in asthma prevalence. Weestimate that by 2020, 29 million Americans could have asthma

    and costs due to asthma could rise to $18 billion per year. Direct and indirect costs are estimated to be more than $11

    billion per year.

    Pew Environmental Health Commission. (2000). Attack asthma: why America needs a public health defense system to battle environmental threats. Retrievedfromhttp://healthyamericans.org/reports/files/asthma.pdf

  • 8/4/2019 Health Assessment Project

    25/32

    Conclusion-Morbidity and Mortality

    According to research, deaths due to asthma are expected to continue to rise, due to lackof knowledge in the disease.

    Today, asthma causes more than 5,000 deaths per year. Unless the rates and severity ofthe disease are slowed, the annual number of asthma-related deaths could double by2020, taking a tremendous personal toll on families across our nation (Moorman, J.,2007). Asthma related deaths may be preventable and could decrease the mortality rate.

    Due to the rapid rise in asthmatic cases, this disease is now viewed as an epidemic; onethat is hitting hardest at the way of the very young, minorities, and the poor.

    Current asthma prevalence was higher in children (8.5%) than in adults (6.7%) and higherin females (8.1%) than in males (6.2%). Male children (9.6%) had higher prevalence thanfemale children (7.4%), but male adults (4.9%) had lower prevalence than female adults(8.4%). The difference in prevalence between blacks and whites was greater for children

    (12.5% versus 7.7%) than for adults (7.6% versus 6.7%). In general, Hispanics (5.4%) hadlower current asthma prevalence than non-Hispanics (7.4%); however, Hispanics of PuertoRican ancestry (14.5%) had higher prevalence than Hispanics ofMexican ancestry (3.9%).Asthma prevalence rates were higher in the Northeast (8.1%) than in the other threeregions and higher in the Midwest (7.5%) than in the South (6.7%) or West (6.8%). Asthmawas more prevalent among persons with family income below the federal povertythreshold (10.3%) than among persons with family income at or above the federal povertythreshold (6.4% to 7.9%) (Moorman, J., 2007)

    Moorman, J., et al. (2007). National Surveillance for asthma united states 1980-2004. CDC.gov. Retrieved fromhttp://www.cdc.gov/mmwr/preview/mmwrhtml/ss5608a1.htm#tab2

  • 8/4/2019 Health Assessment Project

    26/32

    Conclusion-Financial Implications

    The federal government invests quite a bit of money on asthma researchand medications but relatively little in the direct efforts to prevent asthma.

    Asthma treatments and research costs an estimated $11 billion annually.

    Medicare and Medicaid expenditures for asthma treatment exceeded $1

    billion.

    Analysis shows that more than $125 million is spent on asthma relatedresearch.

    Less than $1 million was spent on tracking Asthma cases and about $13

    million is spent on direct prevention research.

    Pew Environmental Health Commission. ( 2000). Attack asthma: why America needs a public health defense system to battle environmental threats. Retrieved

    fromhttp://healthyamericans.org/reports/files/asthma.pdf

  • 8/4/2019 Health Assessment Project

    27/32

    Conclusion-Financial Implications

    Source: Pew Environmental Health Commission. 2000.

  • 8/4/2019 Health Assessment Project

    28/32

    Conclusion-Need for Evidence inManaging and Preventing Disease

    The HHS asthma plan is contained in two documents. The first, HealthyPeople 2010, focuses on treating asthma not preventing it or stopping its rateof growth. The second, Action Against Asthma, lists prevention and tracking asgoals and shows that HHS is heeding the wake-up call to address asthma.Unfortunately, overall the federal government is failing to commit the

    resources necessary to slow or stop the rise in asthma prevalence rates. Thefederal government should be launching prevention efforts that have thepotential to directly and quickly stop new cases of asthma from developing.Analyzing the more than $125 million HHS research budget for 1999, the PewEnvironmental Health Commission found that less than 1% went to asthmatracking a core public health activity. Less than 9% was spent on preventionand less than 17% was dedicated to the study of asthma etiologyresearch intothe factors that cause asthma. Much of the remainder, more than 70%, went to

    asthma treatment and biomedical research to identify basic cellular processesand mechanisms (Pew Environmental Health Commission, 200).

    There is much research and evidence that discuss the importance of preventionand management to decrease the rise in asthma cases. In doing so, the annualasthma related costs drop as well.

    Pew Environmental Health Commission. (2000). Attack asthma: why America needs a public health defense system to battle environmentalthreats. Retrieved fromhttp://healthyamericans.org/reports/files/asthma.pdf

  • 8/4/2019 Health Assessment Project

    29/32

    Conclusion-Implications for Nursing

    Nurses should be well educated in the subject

    Gather data and perform thorough assessment

    Educate patient on the disease, triggers, medication use and techniques, and importance of continuingtreatment

    Help patient to eliminate or reduce triggers and environmental allergens

    Development of individualized Asthma Action Plan

    Adherence to plan and follow up appointments

    Be familiar with the real costs of asthma care to patients in the community including costs of asthma medicines

    Be aware of community resources to help meet the financial needs of asthma patients These may include drugprograms for people with low income, social services, State and local health departments, and voluntaryorganizations.

    Be familiar with the coverage of asthma care that various health insurance policies and government-sponsoredprograms provide before a treatment plan is worked out with the patient.

    Nurses: partners in asthma care. (1995). United States Department of Health and Human Services Public Health Service. Retrieved from EBSCOhost.

  • 8/4/2019 Health Assessment Project

    30/32

  • 8/4/2019 Health Assessment Project

    31/32

  • 8/4/2019 Health Assessment Project

    32/32

    Reference

    Moorman, J., et al. (2007). National Surveillance for asthma united states 1980-2004. CDC.gov. Retrieved fromhttp://www.cdc.gov/mmwr/preview/mmwrhtml/ss5608a1.htm#tab2

    UMMC. (2011).Asthma in adults-risk factors. UMM.edu. Retrieved fromhttp://www.umm.edu/patiented/articles/what_causes_asthma_000004_3.htm

    University of Virginia School ofMedicine. (2011). Asthma attacks. Pediatrics Webmaster. Retrieved fromhttp://www.medicine.virginia.edu/clinical/departments/pediatrics/clinical-services/tutorials/asthma/attacks